Therapy Areas: Infectious Diseases
Smiths Detection Partners with Attomarker in the Development of a Triple Antibody Testing Device for COVID-19
8 July 2020 - - UK-based threat detection and screening technologies provider Smiths Detection has partnered with Attomarker Ltd, a multiplex blood-testing technology company spun out of the Universit...
Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19
8 July 2020 - - US-based biotechnology company Moderna, Inc., (NASDAQ: MRNA), which is developing messenger RNA therapeutics and vaccines, has completed enrollment for both cohorts of the Phase 2 stud...
Aboundbio announces clinical development licence agreement for potent human antibodies against the SARS-CoV-2 virus with SaudiVax Ltd
8 July 2020 - Biotechnology company Aboundbio Inc said on Tuesday that its team has discovered human monoclonal antibodies with exceptional neutralizing activity in the laboratory against SARS-CoV-2, ...
Cerus Touts Successful Inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma
7 July 2020 - - US-based Cerus Corp. (NASDAQ: CERS) is touting study results demonstrating that the INTERCEPT Blood System inactivates SARS-CoV-2, the causative agent for COVID-19, in plasma component...
ChromaDex, NIH-NIAID Rocky Mountain Laboratories Launch Study to Assess the Therapeutic Potential of Niagen in COVID-19 Animal Models
7 July 2020 - - US-based nutraceutical company ChromaDex Corp. (NASDAQ: CDXC) has launched a preclinical study in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), ...
Regeneron Inks Manufacturing, Supply Agreement for BARDA and US Department of Defense for REGN-COV2 Anti-Viral Antibody Cocktail
7 July 2020 - - As part of the US government's Operation Warp Speed, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant secretary for Prepared...